Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 13.35
(0.3%)
CNY 13.35
(0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.13 Million | 276.95 Million | 220.62 Million | 251.61 Million | 179.75 Million | 46.59 Million |
| Net Income | 16.18 Million | 367.61 Million | 158.06 Million | 173.05 Million | 160.79 Million | 105.06 Million |
| Depreciation & Amortization | 118.47 Million | 101.76 Million | 98.94 Million | 85.01 Million | 63.67 Million | 49.85 Million |
| Deferred income taxes | -8.93 Million | -40.23 Million | -21 Million | 18.35 Million | -7.61 Million | -9.51 Million |
| Stock-based compensation | 20.02 Million | 24.69 Million | 5.27 Million | 10.88 Million | 20.33 Million | 7.64 Million |
| Change in working capital | -208.49 Million | -85.44 Million | -62.18 Million | -2.77 Million | -100.44 Million | -115.29 Million |
| Other non-cash items | 37.79 Million | -91.44 Million | 41.53 Million | -32.92 Million | 43 Million | 6.97 Million |
| Investing Cash Flow | -323.6 Million | 50.25 Million | -603.25 Million | -478.96 Million | -351.2 Million | -326.2 Million |
| Investments in PPE | -219.54 Million | -571.61 Million | -529.89 Million | -311.74 Million | -328.06 Million | -299.58 Million |
| Acquisitions | 109.95 Million | 487.93 Million | -47.1 Million | 484.41 Thousand | 2.74 Million | -45.14 Million |
| Investment purchases | -1.19 Billion | -713.93 Million | -1.64 Billion | -865 Million | -690.83 Million | -773.01 Million |
| Sales/Maturities of investments | 983.65 Million | 902.49 Million | 1.56 Billion | 693.52 Million | 639.97 Million | 789.44 Million |
| Other Investing Activities | -104.06 Million | -54.61 Million | 52.02 Million | 3.76 Million | 24.99 Million | 2.09 Million |
| Financing Cash Flow | 54.87 Million | -178.45 Million | 583.14 Million | 138.43 Million | 98.99 Million | 384 Million |
| Debt repayment | -92.44 Million | -749.54 Million | -788.12 Million | -802.45 Million | -630.33 Million | -330.27 Million |
| Dividends payments | -35.21 Million | -30.26 Million | -13.83 Million | -16.44 Million | -29.81 Million | -39.06 Million |
| Common Stock Repurchased | -1.11 Million | -97.22 Thousand | -171.41 Thousand | -531.43 Thousand | -594.36 Thousand | - |
| Common Stock Issuance | - | 97.22 Thousand | 171.41 Thousand | 531.43 Thousand | 594.36 Thousand | - |
| Other Financing Activities | 21.67 Million | 621.11 Million | 1.38 Billion | 981.93 Million | 780.1 Million | 753.34 Million |
| Accounts receivables | -98.83 Million | -213.62 Million | -50.86 Million | -28.22 Million | -17.57 Million | -98.24 Million |
| Accounts payables | -51.16 Million | 351.4 Million | 134.36 Million | 63.33 Million | 37.82 Million | 63.16 Million |
| Inventory | -49.55 Million | -182.98 Million | -124.67 Million | -82.97 Million | -113.08 Million | -70.7 Million |
| Other working capital | 24.33 Million | -40.23 Million | -21 Million | 45.08 Million | -7.61 Million | -44.59 Million |
| Cash at beginning of period | 537.02 Million | 373.63 Million | 175.4 Million | 265.5 Million | 335.52 Million | 232.68 Million |
| Cash at end of period | 273.96 Million | 537.02 Million | 373.63 Million | 174.54 Million | 265.5 Million | 335.52 Million |
| Capital Expenditure | -219.54 Million | -571.61 Million | -529.89 Million | -311.74 Million | -328.06 Million | -299.58 Million |
| Effect of forex changes on cash | -3.45 Million | 14.63 Million | -2.29 Million | -2.04 Million | 2.42 Million | -1.54 Million |
| Net cash flow / Change in cash | -263.05 Million | 163.38 Million | 198.23 Million | -90.95 Million | -70.02 Million | 102.84 Million |
| Free Cash Flow | -210.41 Million | -294.66 Million | -309.26 Million | -60.12 Million | -148.31 Million | -252.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 44.3 Million | 4.89 Million | 14.04 Million | 16.18 Million | -42.95 Million | 23.68 Million |
| Depreciation & Amortization | - | 29.4 Million | 29.4 Million | 118.47 Million | 118.47 Million | -59.62 Million |
| Deferred income taxes | -5.21 Million | - | - | -8.93 Million | - | -39.3 Million |
| Stock-based compensation | - | 5.55 Million | - | 20.02 Million | 20.02 Million | -11.26 Million |
| Change in working capital | - | -262.93 Million | - | -208.49 Million | -124.06 Million | 108.77 Million |
| Other non-cash items | 73.87 Million | 58.96 Million | -68.46 Million | 37.79 Million | 173.4 Million | -58.88 Million |
| Investing Cash Flow | -126.1 Million | 70.85 Million | -25.32 Million | -323.6 Million | -187.16 Million | -82.69 Million |
| Investments in PPE | -11.54 Million | -27.01 Million | -46.12 Million | -219.54 Million | -43.26 Million | -22.01 Million |
| Acquisitions | - | - | - | 109.95 Million | -4.33 Million | 0.93 |
| Investment purchases | -203.97 Million | -228.1 Million | -65.87 Million | -1.19 Billion | -200.44 Million | -106.77 Million |
| Sales/Maturities of investments | 26.91 Million | 423.95 Million | 51.17 Million | 983.65 Million | 48.42 Million | 51.41 Million |
| Other Investing Activities | 62.49 Million | -97.98 Million | 35.48 Million | -104.06 Million | -143.89 Million | -5.31 Million |
| Financing Cash Flow | -138.73 Million | 143.51 Million | 29.38 Million | 54.87 Million | -1.72 Million | 120.63 Million |
| Debt repayment | -136.6 Million | -110.78 Million | -36.96 Million | -92.44 Million | -136.79 Million | -107.07 Million |
| Dividends payments | - | -2.27 Million | -6.94 Million | -35.21 Million | -35.21 Million | -15.39 Million |
| Common Stock Repurchased | - | - | - | -1.11 Million | -1.11 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.12 Million | 35 Million | -629.78 Thousand | 21.67 Million | 134.79 Million | 243.1 Million |
| Accounts receivables | - | 11.42 Million | - | -98.83 Million | -98.83 Million | 48.66 Million |
| Accounts payables | - | - | - | -51.16 Million | - | 54.29 Million |
| Inventory | - | -99.37 Million | - | -49.55 Million | -49.55 Million | 60.11 Million |
| Other working capital | - | -174.98 Million | - | 24.33 Million | 24.33 Million | -54.29 Million |
| Cash at beginning of period | 570.6 Million | 231.08 Million | 273.96 Million | 537.02 Million | 359.83 Million | 369.59 Million |
| Cash at end of period | 565.44 Million | 453.09 Million | 231.08 Million | 273.96 Million | 273.96 Million | 359.83 Million |
| Capital Expenditure | -11.54 Million | -27.01 Million | -46.12 Million | -219.54 Million | -43.26 Million | -22.01 Million |
| Effect of forex changes on cash | - | -2.3 Million | 7.48 Million | -3.45 Million | -21.84 Million | -11.08 Million |
| Net cash flow / Change in cash | -5.15 Million | 222 Million | -42.88 Million | -263.05 Million | -85.86 Million | -9.76 Million |
| Free Cash Flow | 101.42 Million | 7.43 Million | -100.54 Million | -210.41 Million | 81.6 Million | -58.62 Million |
PEO
016360
OSCR
RANASUG
HAA1
SINTERCOM